Parenteral vitamin B12 in macrocytic hemodialysis patients reduced MMA levels but did not change mean red cell volume or hemoglobin

Clinical Nephrology

Volumn 75, Issue 4, 2011, Pages 336-345

  Su, V C H ^a   Shalansky, K ^a   Jastrzebski, J ^b   Martyn, A ^b   Li, G ^b   Yeung, C K ^b   Snyder, F ^c   Zalunardo, N ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anemia; Hemodialysis; Macrocytosis; Methylmalonic acid; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; CYANOCOBALAMIN PLUS FOLIC ACID; FOLIC ACID; HEMOGLOBIN; IRON; METHYLMALONIC ACID; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RENAVITE; TRANSFERRIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CYANOCOBALAMIN DEFICIENCY; ERYTHROCYTE VOLUME; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; IRON THERAPY; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; RETICULOCYTE COUNT; TREATMENT DURATION; VITAMIN BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; INTRAVENOUS DRUG ADMINISTRATION; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANEMIA, MACROCYTIC; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; ERYTHROCYTE INDICES; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; METHYLMALONIC ACID; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 79960945975     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75336     Document Type: Article

References (25)

1. Wickramasinghe SN. Diagnosis of megaloblastic anaemias. Blood Rev. 2006; 20: 299-318.
2. Zachee P, Chew SL, Daelemans R, Lins RL. Erythropoietin resistance due to vitamin B12 deficiency. Am J Nephrol. 1992; 12: 188-191.
3. Moelby L, Nielsen G, Rasmussen K, Jensen MK, Pedersen KO. Metabolic cobalamin deficiency in patients with low to low-normal plasma cobalamins. Scand J Clin Lab Invest. 1997; 57: 209-216.
4. Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med. 2001; 39: 739-746.
5. Obeid R, Kuhlmann M, Kirsch CM, Herrmann W. Cellular uptake of vitamin B12 in patients with chronic renal failure. Nephron Clin Pract. 2005; 99: 42-48.
6. Oh RC, Brown DL. Vitamin B12 deficiency. Am Fam Physician. 2003; 67: 979-986.
7. Moelby L, Rasmussen K, Rasmussen HH. Serum methylmalonic acid in uraemia. Scand J Clin Lab Invest. 1992; 52: 351-354.
8. Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med. 2003; 41: 1478-1488.
9. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate. Clin Chem. 2000; 46: 1277-1283.
10. Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009; 55: 2198-2206
11. Dierkes J, Domröse U, Ambrosch A, Schneede J, Guttormsen AB, Neumann KH, Luley C. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease. Metabolism. 1999; 48: 631-635.
12. Herrmann W, Obeid R, Schorr H, Geisel J. The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings. Curr Drug Metab. 2005; 6: 47-53.
13. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem. 1989; 35: 260-264.
14. Scott SD. Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations for clinical studies. Pharmacotherapy. 2002; 22: 160-165.
15. Nexo E, Hansen M, Rasmussen K, Indgren A, Gräsbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest. 1994; 54 (Suppl): 61-76.
16. Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease. Metabolism. 2003; 52: 168-172.
17. Loikas S, Koskinen P, Irjala K, Löppönen M, Isoaho R, Kivelä SL, Pelliniemi TT. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged. Clin Chem Lab Med. 2007; 45: 197-201.
18. Rasmussen K, Vyberg B, Pedersen KO, Brøchner-Mortensen J. Methylmalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency (letter). Clin Chem. 1990; 36: 1523-1524.
19. Moelby L, RasmussenK,Ring T,NielsenG. Relationship between methylmalonic acid and cobalamin in uremia. Kidney Int. 2000; 57: 265-273.
20. Obeid R, Kuhlmann M, Köhler H, Herrmann W. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. Clin Chem. 2005; 51: 196-201.
21. Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J AmGeriatr Soc. 2000; 50: 1789-1795.
22. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, Dresser GK, Spence JD. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010; 303: 1603-1609.
23. Koyama K, Yoshida A, Takeda A, Morozumi K, Fujinami T, Tanaka N. Abnormal cyanide metabolism in uraemic patients. Nephrol Dial Transplant. 1997; 12: 1622-1628.
24. Wang R. Is H2S a stinky remedy for atherosclerosis? Arterioscler Thromb Vasc Bio. 2009; 29: 156-157.
25. Koyama K, Ito A, Yamamoto J, Nishio T, Kajikuri J, Dohi Y, Ohte N, Sano A, Nakamura H, Kumagai H, Itoh T. Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis. Am. J Kidney Dis. 2010; 55: 1069-1078.